Levy et al., 1998 - Google Patents
Matrix metalloproteinase inhibitors: a structure− activity studyLevy et al., 1998
- Document ID
- 3767731829544878687
- Author
- Levy D
- Lapierre F
- Liang W
- Ye W
- Lange C
- Li X
- Grobelny D
- Casabonne M
- Tyrrell D
- Holme K
- Nadzan A
- Galardy R
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
Modifications around the dipeptide-mimetic core of a hydroxamic acid based matrix metalloproteinase inhibitor were studied. These variations incorporated a variety of natural, unnatural, and synthetic amino acids in addition to modifications of the P1 'and P3 …
- 239000003771 matrix metalloproteinase inhibitor 0 title abstract description 28
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Levy et al. | Matrix metalloproteinase inhibitors: a structure− activity study | |
| US5239078A (en) | Matrix metalloprotease inhibitors | |
| US5189178A (en) | Matrix metalloprotease inhibitors | |
| KR100352316B1 (en) | Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors | |
| US5696147A (en) | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors | |
| JP3347331B2 (en) | Heterocyclic metalloprotease inhibitors | |
| Fray et al. | A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers | |
| Yasuma et al. | Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption | |
| CZ390697A3 (en) | Reversible inhibitor of cystein protease, method of inhibiting thereof, cystein protease inhibited thereby, pharmaceutical composition containing thereof, method of treating disorders connected with the cystein protease, detection method thereof and diamine compounds | |
| JPH11503455A (en) | Thrombin inhibitor | |
| KR20000035925A (en) | Phosphinic acid amides as matrix metalloprotease inhibitors | |
| JPH11502523A (en) | Lactam-containing hydroxamic acid derivatives, their preparation and use as inhibitors of metalloprotease substrates | |
| EA009291B1 (en) | Use of effectors of glutaminyl and glutamate cyclases | |
| JP6251279B2 (en) | Aggrecanase inhibitor | |
| JPH10512241A (en) | Hydroxamic acid-containing inhibitors of matrix metalloproteases | |
| US20080125354A1 (en) | Selective inhibition of matrix metalloproteinases | |
| FI113965B (en) | 8-Oxo-4-oxa-1,7-diazatricyclooctadecatetraen-9-ylcarbamoyl Derivatives as Matrix Metal Protease Inhibitors | |
| TWI361186B (en) | New compounds | |
| AU6554294A (en) | Synthetic matrix metalloprotease inhibitors and uses thereof | |
| ZA200109675B (en) | Inhibitors of metalloproteinases. | |
| JP3325017B2 (en) | Novel metalloprotease inhibitors, their therapeutic use and methods for preparing starting compounds in their synthesis | |
| EP1212300B1 (en) | Azacycloalkanone serine protease inhibitors | |
| KR102649684B1 (en) | Gelatinase inhibitors and uses thereof | |
| ZA200103605B (en) | Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases. | |
| Storgaard | Design, Synthesis and Biological Activity of Novel Reversible Peptidyl FVIIa Inhibitors Rh-Catalyzed Enantioselective Synthesis of Diaryl Amines |